CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2024		33,629,169
Beginning balance at Dec. 31, 2024	$ 1,366,974	$ 34	$ 827,796	$ 537,184	$ 1,960
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	16,551			16,551
Stock-based compensation	1,201		1,210	(9)
Issuance of restricted and deferred stock units (in shares)		31,587
Issuance of restricted and deferred stock units	(908)		(908)
Employee stock purchase plan (in shares)		26,129
Employee stock purchase plan	1,116		1,116
Common stock issuance, net of costs (in shares)		495,900
Common stock issuance, net of costs	26,545		26,545
Dividends paid	(14,142)			(14,142)
Ending balance (in shares) at Mar. 31, 2025		34,182,785
Ending balance at Mar. 31, 2025	$ 1,397,337	$ 34	855,759	539,584	1,960
Beginning balance (in shares) at Dec. 31, 2025	36,118,242	36,118,242
Beginning balance at Dec. 31, 2025	$ 1,540,771	$ 36	958,188	581,080	1,467
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	19,013			19,013
Stock-based compensation	1,202		1,212	(10)
Issuance of restricted and deferred stock units (in shares)		37,809
Issuance of restricted and deferred stock units	(616)		(616)
Employee stock purchase plan (in shares)		23,112
Employee stock purchase plan	1,023		1,023
Common stock issuance, net of costs (in shares)		5,660,377
Common stock issuance, net of costs	288,601	$ 6	288,595
Dividends paid	$ (15,912)			(15,912)
Ending balance (in shares) at Mar. 31, 2026	41,839,540	41,839,540
Ending balance at Mar. 31, 2026	$ 1,834,082	$ 42	$ 1,248,402	$ 584,171	$ 1,467